About the Company
We do not have any company description for Protara Therapeutics, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Protara Therapeutics, Inc.
Protara Therapeutics Reports Q2 2025 Financial Results
Protara Therapeutics, Inc. ( ($TARA) ) has released its Q2 earnings. Here is a breakdown of the information Protara Therapeutics, Inc. presented ...
Protara Therapeutics, Inc. Added to Russell 3000® Index ... - Nasdaq
Protara Therapeutics, Inc. has been added to the Russell 3000® Index as of June 30, 2025, marking a significant milestone for the clinical-stage biotechnology company focused on developing ...
Protara Therapeutics Announces Fourth Quarter and Full Year 2024 ...
--Protara Therapeutics, Inc., a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today provided a business update and announced financial ...
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq ...
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4) Provided by GlobeNewswire Jul 1, 2025, 1:12:07 PM ...
Protara Therapeutics Announces Third Quarter 2024 ... - Seeking Alpha
NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics (TARA), Inc. , a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today ...
Protara Therapeutics Announces First Quarter 2024 Financial Results and ...
NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases ...
Protara Therapeutics: Q2 Earnings Snapshot
(TARA) on Monday reported a loss of $15 million in its second quarter. On a per-share basis, the New York-based company said it had a loss ...
Protara Therapeutics Announces Fourth Quarter and Full Year 2023 ...
NEW YORK, March 13, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases ...
Protara Therapeutics Announces Fourth Quarter and Full Year 2022 ...
NEW YORK, March 08, 2023 (GLOBE NEWSWIRE) -- Protara Therapeutics (TARA), Inc. , a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today ...
Similar Companies
Loading the latest forecasts...